The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: Regulation of D1/D2 interactions by muscarinic receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 972-982

  Wang, John Q ^a   McGinty, Jacqueline F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; ETICLOPRIDE; MORPHINE; MUSCARINIC RECEPTOR; PRODYNORPHIN; SCOPOLAMINE; SUBSTANCE P; BENZAZEPINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; MESSENGER RNA; NEUROPEPTIDE; SALICYLAMIDE DERIVATIVE; SK&F 82958;

ARTICLE; BRAIN DEPTH STIMULATION; DOPAMINE BLOOD LEVEL; EVOKED RESPONSE; GENE EXPRESSION; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RNA ANALYSIS; ANIMAL; ANIMAL BEHAVIOR; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; CORPUS STRIATUM; DOPAMINE AGONISTS; GENE EXPRESSION REGULATION; MALE; NEUROPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, MUSCARINIC; RNA, MESSENGER; SALICYLAMIDES;

EID: 0030610433     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. 2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 518: 193-198, 1990.
2. ANDERSON, J. J., CHASE, T. N. AND ENGBER, T. M.: Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats. Brain Res. 623: 189-194, 1993.
3. ANDERSON, P. H. AND JANSEN, J.: Dopamine receptor agonists: selectivity and dopamine receptor efficacy. Eur. J. Pharmacol. 188: 335-347, 1990.
4. ANGULO, J. A., CADET, J., WOOLLEY, C., SUBER, F. AND MCEWEN, B.: Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat. J. Neurochem. 54: 1889-1894, 1990.
5. ANGULO, J. A. AND MCEWEN, B. S.: Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19: 1-28, 1994.
6. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol. Toxicol. 62: 121-130, 1988.
7. AUGOOD, S. J., FAULL, R. L. AND EMSON, P. C.: Contrasting effects of raclopride and SCH 23390 on the cellular content of proenkephalin A mRNA in rat striatum: A quantitative non-radioactive in situ hybridization study. Eur. J. Pharmacol. 4: 102-112, 1992.
8. AUGOOD, S. J., WESTMORE, K., FAULL, R. L. M. AND EMSON, P. C.: Neuroleptics and striatal neuropeptide gene expression. Prog. Brain Res. 99: 181-199, 1993.
9. BANNON, M. J., HAVERSTICK, D. M., SHIBATA, K. AND POOSCH, M. S.: Preprotachykinin gene expression in the forebrain: regulation by dopamine. Ann. N.Y. Acad. Sci. 632: 31-37, 1991.
10. BANNON, M. J., KELLAND, M. AND CHIODO, L.: Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum. J. Neurochem. 52: 859-862, 1989.
11. 5 dopamine receptors in primate brain. J. Neurosci. 15: 7821-7836, 1995.
12. BERNARD, V., NORMAND, E. AND BLOCH, B.: Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12: 3591-3600, 1992.
13. 2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J. Neurochem. 54: 2145-2148, 1990.
14. CABOCHE, J., VERNIER, P., ROGARD, M. AND BESSON, M. J.: Haloperidol increases PPE mRNA levels in the caudal part of the nucleus accumbens in the rat. NeuroReport 4: 551-554, 1993.
15. 2 dopamine receptors and the regulation of striatal acetylcholine release in vivo. Prog. Brain Res. 98: 201-207, 1993.
16. 1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 259: 1064-1072, 1991.
17. 1 receptor stimulation increases striatal acetylcholine release in the rat. Eur. J. Pharmacol. 186: 335-338, 1990.
18. 2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Mol. Brain Res. 35: 237-248, 1996.
19. DEBOER, P. AND ABERCROMBIE, E. D.: Further characterization of the role of substantia nigra in the modulation of the release of acetylcholine in the straitum of awake rats. Soc. Neurosci. Abstr. 20: 285, 1994.
20. DI CHIARA, G., MORELLI, M. AND CONSOLO, S.: Modulatory functions of neurotransmitters in the striatum: ACH/dopamine/NMDA interactions. TINS 17: 228-233, 1994.
21. ELLINWOOD, E. H. AND BALSTER, R. L.: Rating the behavioral effects of amphetamine. Eur. J. Pharmacol. 28: 35-41, 1974.
22. FLORIN, S. M., KUCZENSKI, R. AND SEGAL, D. S.: Amphetamine-induced changes in behavior and caudate extracellular acetylcholine. Brain Res. 581: 53-55, 1992.
23. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432, 1990.
24. GOU, N., ROBERTSON, G. S. AND FIBIGER, H. C.: Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res. 588: 164-167, 1992.
25. HANSON, G. R., MERCHANT, K. M., LETTER, A. A., BUSH, L. AND GIBB, J. W.: Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors. Eur. J. Pharmacol. 144: 245-246, 1987.
26. HAVERSTICK, D., RUBENSTEIN, A. AND BANNON, M.: Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 248: 858-862, 1989.
27. HONG, J. S., YANG, H. T. T., GILLIN, J. C. AND COSTA, E.: Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons. Adv. Biochem. Psychopharmacol. 24: 223-232, 1980.
28. HONG, J. S., YOSHIKAWA, K., KANAMATSU, T. AND SABOL, S. L.: Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Fed. Proc. 44: 2535-2539, 1985.
29. HULME, E. C., BIRDSALL, N. J. M. AND BUCKLEY, N. J.: Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30: 633-673, 1990.
30. HURD, Y. L. AND HERKENHAM, M.: Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol. Brain Res. 16: 97-104, 1992.
31. JIANG, H. K., MCGINTY, J. F. AND HONG, J. S.: Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 507: 57-64, 1990.
32. KEBABIAN, J. W., BRITTON, D. R., DENINNO, M. P., FERNER, R., SMITH, L., JENNER, P., SCHOENLEBER, R. AND WILLIAM, M. W.: A-77636: A potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur. J. Pharmacol. 229: 203-209, 1992.
33. KEEFE, K. A. AND GERFEN, C. R.: D1-D2 dopamine receptor synergy in striatum: Effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66: 903-913, 1995.
34. 2 synergism and receptor supersensitivity. Proc. Natl. Acad. Sci. U.S.A. 90: 7451-7455, 1993.
35. LE MOINE, C., NORMAND, E., GUITTENY, A. F., FOUQUE, B., TEOULE, R. AND BLOCH, B.: Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. U.S.A. 87: 230-234, 1990.
36. LE MOINE, C., AND BLOCH, B.: D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355: 418-426, 1995.
37. LINDEFORS, N., HURD, Y. L., O'CONNOR, W. T., BRENE, S., PERSSON, H. AND UNGERSTEDT, U.: Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens. Neuroscience 48: 439-448, 1992.
38. LUCAS, L. R. AND HARLAN, R. E.: Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum. Mol. Brain Res. 30: 181-195, 1995.
39. MANDEL, R. J., LEANZA, G., NILSSON, O. G. AND ROSENGREN, E.: Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine. Brain Res. 653: 57-65, 1994.
40. 1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats. Pharmacol. Biochem. Behav. 46: 269-274, 1993.
41. 2 antagonists. Neuroscience 25: 525-532, 1988.
42. 2 interaction. Eur. J. Pharmacol. 160: 377-384, 1989.
43. NISENBAUM, L. K., KITAI, S. T. AND GERFEN, C. R.: Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: Effects of systemic and central administration of quinpirole and scopolamine. Neuroscience 63: 435-449, 1994.
44. 1 dopamine receptor. Neuropharmacology 28: 401-405, 1989.
45. PAUL, M. L., GRAYBIEL, A. M., DAVID, J. C., ROBERTSON, H. A.: D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12: 3729-3741, 1992.
46. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, 1986.
47. PFEIFFER, F. R., WILSON, J. W., WEINSTOCK, J., KUO, G. Y., CHAMBERS, P. A., HOLDEN, K. G., HAHN, R. A., WARDELL, J. R. JR., TOBIA, A. J., SETLER, P. E. AND SARAU, H. M.: Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. J. Med. Chem. 25: 352-358, 1982.
48. 2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Mol. Brain Res. 13: 35-41, 1992.
49. ROBERTSON, H. A., PAUL, M. L., MORATALLA, R. AND GRAYBIEL, A. M.: Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can. J. Neurol. Sci. 18: 380-383, 1991.
50. 1 dopamine receptor-activated c-Fos. Brain Res. 523: 288-290, 1990.
51. SETLER, P. E., SARAU, H. M., ZIRKLE, C. L., SAUNDERS, H. L.: The central effects of a novel dopamine agonist. Eur. J. Pharmacol. 50: 419-430, 1978.
52. SIVAM, S. P.: Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmacol. Exp. Ther. 250: 818-824, 1989.
53. SMILEY, P. L., JOHNSON, M., BUSH, L., GIBB, J. W. AND HANSON, G. R.: Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253: 938-943, 1990.
54. SMITH, A. J. W. AND MCGINTY, J. F.: Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res. 21: 359-362, 1994.
55. SOGHOMONIAN, J. J.: Differential regulation of glutamate decarboxylase and preproenkephalin mRNA levels in the rat striatum. Brain Res. 640: 146-154, 1994.
56. STEINER, H. AND GERFEN, C. R.: Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13: 5066-5081, 1993.
57. SURMEIER, D. J., REINER, A., LEVINE, M. S. AND ARIANO, M. A.: Are neostriatal dopamine receptors co-localized? TINS 16: 299-305, 1993.
58. WANG, J. Q., SMITH, A. J. W. AND MCGINTY, J. F.: A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin mRNA expression in rat forebrain. Neuroscience 68: 83-95, 1995.
59. WANG, J. Q. AND MCGINTY, J. F.: Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673: 262-274, 1995a.
60. WANG, J. Q. AND MCGINTY, J. F.: Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine and methamphetamine in rat forebrain. J. Pharmacol. Exp. Ther. 273: 909-917, 1995b.
61. 2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22: 114-122, 1996a.
62. 1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience 72: 601-616, 1996b.
63. WANG, J. Q. AND MCGINTY, J. F.: Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience 75: 43-56, 1996c.
64. WANG, J. Q. AND MCGINTY, J, F.: Glutamatergic and cholinergic regulation of immediate early gene and neuropeptide gene expression in the striatum. In Pharmacological Regulation of Gene Expression in the CNS, ed. by K. M. Merchant, pp. 81-113, CRC Press, Boca Raton, FL, 1996d.
65. WANG, J. Q. AND MCGINTY, J. F.: Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res. 748: 62-71, 1997.
66. WEINER, D. M., LEVEY, A. AND BRANN, M. R.: Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. U.S.A. 87: 7050-7054, 1990.
67. WIRTSHAFTER, D. AND ASIN, K. E.: Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35: 85-91, 1994.
68. YUNG, K. K., SMITH, A. D., LEVEY, A. I. AND BOLAM, J. P.: Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: Evidence from dopamine receptor and neuropeptide immunostaining. Eur. J. Neurosci. 8: 861-869, 1996.